AB011. SOH24AB_147. Radiotherapy for muscle invasive bladder cancer (MIBC): friend or foe?—A 10-year review of radiotherapy use for MIBC in the southeast of Ireland

Background: Trimodality therapy (TMT) combines transurethral resection of bladder tumour (TURBT), radiotherapy (RT), and chemotherapy. European Association of Urology guidelines contain a "strong" recommendation that TMT can "be offered as an alternative to select patients, for whom radical cystectomy (RC) is not an option". Five-year survival ranges 36–74%, with salvage cystectomy rates 10–30%.